↓ Skip to main content

CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors

Overview of attention for article published in BMC Cancer, February 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent
4 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
88 Dimensions

Readers on

mendeley
92 Mendeley
citeulike
1 CiteULike
connotea
2 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors
Published in
BMC Cancer, February 2010
DOI 10.1186/1471-2407-10-66
Pubmed ID
Authors

Cristina Patru, Luciana Romao, Pascale Varlet, Laure Coulombel, Eric Raponi, Josette Cadusseau, François Renault-Mihara, Cécile Thirant, Nadine Leonard, Alain Berhneim, Maria Mihalescu-Maingot, Jacques Haiech, Ivan Bièche, Vivaldo Moura-Neto, Catherine Daumas-Duport, Marie-Pierre Junier, Hervé Chneiweiss

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
United States 1 1%
Portugal 1 1%
France 1 1%
Unknown 87 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 25%
Researcher 18 20%
Student > Master 8 9%
Student > Bachelor 6 7%
Professor 5 5%
Other 17 18%
Unknown 15 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 32 35%
Medicine and Dentistry 16 17%
Biochemistry, Genetics and Molecular Biology 10 11%
Neuroscience 6 7%
Immunology and Microbiology 2 2%
Other 9 10%
Unknown 17 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2023.
All research outputs
#4,906,861
of 23,578,918 outputs
Outputs from BMC Cancer
#1,265
of 8,483 outputs
Outputs of similar age
#20,719
of 95,347 outputs
Outputs of similar age from BMC Cancer
#10
of 40 outputs
Altmetric has tracked 23,578,918 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,483 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,347 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.